A new, retrospective study trying to tease out the benefits of MitraClip procedures according to the etiology of mitral regurgitation (MR) hints that, compared with conservative management, ...

MitraClip, a catheter-delivered device, has been approved by the US Food and Drug Administration (FDA) for treatment of patients with significant symptomatic degenerative mitral regurgitation who are ...

Patients with secondary mitral regurgitation (MR) who were left with high gradients after a MitraClip procedure were not inherently at a disadvantage in their subsequent clinical outcomes, according ...

Please provide your email address to receive an email when new articles are posted on . Transcatheter mitral valve repair improved outcomes and symptoms in patients with moderate to severe mitral ...

Abbott Vascular has announced today that its first-in-class, catheter-based MitraClip device has been approved by the FDA for the treatment of patients with mitral regurgitation. Perspective from ...

Why are we asking for donations? Why are we asking for donations? This site is free thanks to our community of supporters. Voluntary donations from readers like you keep our news accessible for ...

A seemingly simple but sophisticated clip may usher in a “new era” for patients suffering from a severe and difficult-to-treat complication of heart failure, according to a new study. The device, ...

In 2013, the FDA approved an implantable device to treat leaky heart valves. Among its inventors was Mehmet Oz, the former television personality and former U.S. Senate candidate widely known as "Dr.

Cardiovascular diseases or heart problems are still one of the leading causes of death across the globe, and these include such conditions as coronary artery diseases, hypertension, stroke, and many ...

The nearly 2 million Americans with severe heart failure face unique challenges. Simple tasks such as short walks and climbing the stairs at home can lead to shortness of breath. Those with the ...

A study from Abbott found that employing its cardiac valve repair implant during earlier phases of heart failure—when a patient’s leaky mitral valve is still considered to be functional—could lead to ...

Failed transcatheter edge-to-edge repair of functional and degenerative mitral regurgitation (MR) with the MitraClip (Abbott) is relatively uncommon at high-volume centers but associated with a high ...